Buying replicel stock thread
Collapse
X
-
Not trying to sway you one way or other. But, if you invested in them because you believe in their team and the science, then there is no reason to get out. The fundamentals are the same as they were a week ago. The trial data will be the make or break. Not some loud mouth talk show host who made some ill advised comments in a news letter.Leave a comment:
-
Well, I'm worried that I should have sold at 2.60, but now that it's in the mid-1.00's, I might as well ride thise train all the way to the station. No point in selling now, go big or go home and all that jazz.Leave a comment:
-
some people have no grasp of the sheer amount of money traded hands everyday on the open stock market in stocks, not to mention options and other instruments. Thats not even talking about the derivatives market that is totally unregulated...
Also, one man isn't going to be able to offload 90k shares in such a thinly traded stock without seriously moving the market - against him. It would take *days* to do that and he wouldn't get them all out at one price either, he'd get various size lots at various prices.Leave a comment:
-
really?
if somebody bought on march 3 about 90000 shares for about ~$2.0 per share and could sell them easily last week or on friday (and he could easily!) for about ~2.7 per share - yup, about $60k gain is a ridiculously small gain for "somebody" who actually expected essentially more than just ~2.7 per share. i agree.Leave a comment:
-
if somebody bought on march 3 about 90000 shares for about ~$2.0 per share and could sell them easily last week or on friday (and he could easily!) for about ~2.7 per share - yup, about $60k gain is a ridiculously small gain for "somebody" who actually expected essentially more than just ~2.7 per share. i agree.Leave a comment:
-
-
-
-
Leave a comment:
-
i pray all these hair loss experts on TBT takes matter into their own hands to come up with a solution instead of just digging and digging and digging then trashing each other with dirt.Leave a comment:
-
TapImmune (OTC: TPIV), RepliCel Life Sciences (OTC: REPCF) and American Fiber Green Products (AFBG) are three small cap stocks (the first two being biotech stocks and the last being an eco-friendly green stock) that have recently been the subject of promotions and hence, could use a reality check. After all, paid promotions can work both ways as they send a stock upward thanks to mentions in investment newsletters and investor alerts but then gravity forces the stock back down to earth unless the companies promoted are actually viable. So can small cap stocks TapImmune (TPIV), RepliCel Life Sciences (REPCF) and American Fiber Green Products (AFBG) move beyond paid promotions and stand on their own feet or should investors just give all three a pass? Here is a reality check to help you decide:
RepliCel Life Sciences is developing a scientific technology that has the potential to become the world's first, minimally invasive, permanent solution for hair loss in men and women. According to various disclosures, various $33k, $40k and $45k transactions have been paid to promote RepliCel Life Sciences. However and on Monday, RepliCel Life Sciences only rose 0.49% to $2.06 (REPCF has a 52 week trading range of $1.60 to $3.50 a share) for a market cap of $88.89 million but the stock is down 12.3% since the start of the year as well as over the past year. Hence and so far, the promotions appear to not be helping RepliCel Life Sciences just yet while the stock also has just announced the closing of a private placement where it issued 430,033 units at a price of $1.50 per unit for gross proceeds of $645,050. Investors should be aware that RepliCel Life Sciences has reported no revenues; net losses C$2.54M (2010), C$0.56M (2009) and C$0.02M (2008) for the past three years and net losses of C$0.89M (most recent reporting quarter), C$1.81M and C$0.71M for the first three quarters of 2011; and had C$1.21M in cash and short-term investments to cover C$0.27M in current liabilities at the end of last September. Nevertheless and if RepliCel Life Sciences does find or have a cure or permanent solution for hair loss, the stock won’t need any promotions as it will surge on its own merits.Leave a comment:
-
What I see is a whole lot of churning going on. Current owners of shares are selling and new buyers are coming in. That is why we have higher volume, yet the shares are not going anywhere.
So far, Replicel has paid the following companies to push info on their stock:
Blue Wave Advisors 45,000
TooNiceStocks 33,000
Link:
This in addition to NBT. I am not an expert on penny stocks, don't normally invest in them. I have made an exception on this one. I don't know, maybe this is something that an unknown company needs to do so that they don't end up announcing their discovery to the wind and realize that the only people who know about it are a few chat room members.
Taking a glass is half full view, if there is greater visibility out there for Replicel, maybe some people don't necessarily buy the stock immediately, but have it on their watch list, and if results are good, and the stock takes off a bit, there could be additional buyers of the stock.Leave a comment:
-
Stop analysizing stock movements and volumes they indicate nothing but speculations and/or opportunists trying to grab some quick bucks....
at this point of time anywayLeave a comment:
Leave a comment: